Skip to main content
Supriya Lifescience Limited logo

Supriya Lifescience Limited — Investor Relations & Filings

Ticker · SUPRIYA ISIN · INE07RO01027 LEI · 894500RBVJX1EOJP0Y02 BSE.NS Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2025-01-01 Regulatory Filings
Country IN India
Listing BSE.NS SUPRIYA

About Supriya Lifescience Limited

https://www.supriyalifescience.com

Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.

Recent filings

Filing Released Lang Actions
News Verification
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges responding to a query about a news item related to the company's share price movement. It clarifies that there is no undisclosed material information affecting the company's operations or performance and states compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations. The document does not contain any financial data, report, or detailed analysis. It is a regulatory communication clarifying market rumors and confirming compliance with disclosure obligations. The document length is short (3506 characters) and it is not a report itself but a regulatory filing responding to an inquiry. Therefore, it fits best under Regulatory Filings (RNS).
2025-01-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the closure of the trading window for insiders and designated persons. It references the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and states that the trading window will be closed from January 1, 2025, until 48 hours after the declaration of the unaudited financial results for the quarter and nine months ended December 31, 2024. The document does not contain any financial data or results itself, nor does it provide a report or detailed financial analysis. Instead, it is an announcement related to insider trading compliance and timing of trading restrictions ahead of financial results. The document length is short (2472 characters), and it is clearly an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance-related notices that do not fit other categories.
2024-12-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the schedule of analyst and institutional investor meetings, including a plant visit and group meeting. It mentions that the investor presentation has been uploaded on the company's website and stock exchanges. The document is short (2516 characters) and serves as an announcement of the schedule and availability of the investor presentation rather than the presentation itself. There are no financial statements or detailed financial data included. Therefore, this document is best classified as an Investor Presentation announcement or related update. However, since it is primarily an announcement about the schedule and availability of the presentation, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than the presentation itself (IP).
2024-12-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges informing about scheduled meetings with analysts and institutional investors. It references the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges. The document does not contain financial statements or detailed financial data but rather announces the schedule of investor meetings and the availability of the presentation. The document length is 2661 characters, which is relatively short and fits the pattern of an announcement rather than the full investor presentation itself. Therefore, this document is best classified as an Investor Presentation announcement or update. According to the filing definitions, the appropriate category for detailed presentations for investors focusing on financials, strategy, and market position is 'Investor Presentation' (IP). Since the document states the presentation is uploaded and provides meeting details, it aligns with the IP category rather than a report publication announcement or regulatory filing.
2024-12-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of analyst and institutional investor meetings. It mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges. The document is short (2649 characters) and serves as an announcement of the upcoming investor meetings and the availability of the presentation, rather than containing the presentation or detailed financial data itself. It is a regulatory disclosure under SEBI Listing Regulations about investor interaction schedules and presentation availability. Therefore, this document is best classified as an Investor Presentation announcement rather than the presentation itself. Given the nature and content, the appropriate classification is Investor Presentation (IP).
2024-12-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a letter addressed to stock exchanges informing about a scheduled meeting between company officials and analysts/institutional investors. It mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges. The document is short (2654 characters) and primarily serves as a notification of the meeting schedule and the availability of the presentation, rather than containing the presentation itself or detailed financial data. It is an announcement related to investor relations and presentation scheduling, not the presentation document itself. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor communication and presentation scheduling.
2024-12-17 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.